2 new PET tracers may best FDG in cancer imaging
Cancer detection could receive a boost from two new radiotracers that have...Read more on AuntMinnie.comRelated Reading: Later PET/CT follow-up helps for oropharyngeal cancer Ga-68 PSMA-11 PET/MRI improves prostate cancer detection New PET tracer could aid melanoma detection FDG-PET/CT fails for peripheral T-cell lymphoma outcomes PET/CT predicts success of rad therapy for spinal mets (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2019 Category: Radiology Source Type: news

Later PET/CT follow-up helps for oropharyngeal cancer
Using PET/CT for follow-up at a later interval than what's recommended by existing...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT aids in melanoma treatment assessment CT lung screening can catch recurring head, neck cancer ASTRO: Blood test confirms HPV-related cancer remission FDG-PET/CT fails for peripheral T-cell lymphoma outcomes FDG-PET/CT helps stage men with breast cancer, too (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news

New study shows HPV not likely transmittable through the hand
(McGill University) Commonly known as HPV, Human papillomavirus is a virus that infects the skin and genital area, in many cases leading to a variety of genital, anal, and oropharyngeal cancers in men and women. Strong evidence exists showing that penetrative genital sex and oral sex can transmit HPV. However, while HPV is also often detected in the hands, the question of whether hand-genital contacts can transmit HPV has long been a source of debate among researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2019 Category: International Medicine & Public Health Source Type: news

HPV Gene Expression Signatures, Prognosis in Cervical Cancers
Cancer Network spoke with Curtis Pickering, PhD, about prognostic gene expression signatures for HPV-positive oropharyngeal and cervical cancers. (Source: CancerNetwork)
Source: CancerNetwork - January 28, 2019 Category: Cancer & Oncology Authors: Bryant Furlow Source Type: news

Cisplatin Superior to Cetuximab for HPV + Oropharyngeal Cancer
Toxicity similar in two treatment groups at 24 months, but worse tumor control with cetuximab (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 17, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Radiology, Journal, Source Type: news

Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer
MONDAY, Dec. 17, 2018 -- For treatment of human papillomavirus (HPV)-positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 17, 2018 Category: Pharmaceuticals Source Type: news

ASTRO: Oropharynx CA Survival Rates Worse With RT/Cetuximab
FRIDAY, Oct. 26, 2018 -- For patients with locoregionally advanced human papillomavirus (HPV)-related oropharynx cancer, radiation/cetuximab results in inferior overall and progression-free survival versus radiation/cisplatin, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2018 Category: Pharmaceuticals Source Type: news

Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer
A plasma circulating tumor human papillomavirus (HPV) DNA test had a negative predictive value of 100% and predicts patients at risk for cancer recurrence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ASTRO: Blood test confirms HPV-related cancer remission
A biomarker blood test can accurately determine if patients with oropharyngeal...Read more on AuntMinnie.comRelated Reading: ASTRO: Prostate RT works better than expected in black men ASTRO: SABR is effective for oligometastatic cancers ASTRO: Weekly breast radiation therapy is safe ASTRO: AI's rad therapy future is in predicting outcomes ASTRO: SBRT works well for less risky prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2018 Category: Radiology Source Type: news

Biomarker blood test confirms remission in patients with HPV+ oral cancer
(American Society for Radiation Oncology) A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC) are free from cancer following radiation therapy. Findings will be presented today at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2018 Category: Cancer & Oncology Source Type: news

HPV blood test shows promise for tracking head and neck cancer after treatment
(UNC Lineberger Comprehensive Cancer Center) Researchers will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology in San Antonio on Tuesday, Oct. 23, from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2018 Category: Cancer & Oncology Source Type: news

Patients with HPV-positive oropharynx cancer should receive chemoradiation
(European Society for Medical Oncology) Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy, according to late-breaking research reported at the ESMO 2018 Congress in Munich. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 22, 2018 Category: International Medicine & Public Health Source Type: news

RT and Surgery Appear Equally Viable for Oropharyngeal Cancer
(MedPage Today) -- But chemo add-on to RT was tied to increased gastrostomy dependence (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - September 25, 2018 Category: Radiology Source Type: news

Trends in HPV-Associated Cancers -- United States, 1999-2015 Trends in HPV-Associated Cancers -- United States, 1999-2015
This report examined trends in cervical cancer, as well as oropharyngeal, vulvar, vaginal, penile, and anal cancers.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Late Lower Cranial Neuropathy in Oropharyngeal Cancer Patients
Survivors of oropharyngeal cancers who developed late lower cranial neuropathy reported having worse treatment-related symptoms. (Source: CancerNetwork)
Source: CancerNetwork - September 14, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Total of 43,371 New Cases of HPV - Associated Cancers in 2015
Decreases in cervical cancer, vaginal SCC from 1999 to 2015; increases in oropharyngeal, anal, vulvar SCC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 11, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

Total of 43,371 New Cases of HPV-Associated Cancers in 2015
TUESDAY, Sept. 11, 2018 -- A total of 43,371 new cases of human papillomavirus (HPV)-associated cancers were reported in 2015, with oropharyngeal squamous cell carcinoma (SCC) being the most common HPV-associated cancer, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 11, 2018 Category: Pharmaceuticals Source Type: news

Test Oropharyngeal Cancers for HPV
(MedPage Today) -- ASCO endorses CAP guideline (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 10, 2018 Category: American Health Source Type: news

Top HPV-Associated Cancer Is Now Oropharyngeal
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 24, 2018 Category: General Medicine Source Type: news

CDC: Top HPV-Associated Cancer Is Now Oropharyngeal CDC: Top HPV-Associated Cancer Is Now Oropharyngeal
Also, the Centers for Disease Control and Prevention reports that over the past 15 years, women's HPV-associated cancers are in decline and men's are on the rise.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

No Change in Standard of Care for HPV+ Oropharyngeal Cancer No Change in Standard of Care for HPV+ Oropharyngeal Cancer
Interim results of a large phase III trial showed that patients treated with a cetuximab regimen has worse survival than those treated with cisplatin plus radiation therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 14, 2018 Category: American Health Source Type: news

Cetuximab+RT found to be inferior to standard treatment in HPV+ oropharyngeal cancer
(NIH/National Cancer Institute) An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy and cetuximab is associated with worse overall and progression-free survival compared to the current standard treatment with radiation and cisplatin. The trial was designed to see if cetuximab with radiation would be less toxic than cisplatin with radiation without compromising survival for patients with the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2018 Category: Cancer & Oncology Source Type: news

Older Adults Increasingly Have HPV + Oropharyngeal Cancers
Regardless of age, favorable survival conferred by an HPV - positive tumor status (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 13, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pathology, Geriatrics, Journal, Source Type: news

Older Adults Increasingly Have HPV & #43; Oropharyngeal Cancers
WEDNESDAY, June 13, 2018 -- Human papillomavirus (HPV)-positive oropharyngeal cancers are increasing among older adults, according to a study published online April 30 in Cancer. Melina J. Windon, M.D., from Johns Hopkins University in Baltimore,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2018 Category: Pharmaceuticals Source Type: news

Symptom Burden Highest 1 Month After Cancer Dx
(MedPage Today) -- Supportive care needed for moderate-to-severe symptoms, especially in oropharyngeal, respiratory cancers (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - March 8, 2018 Category: Respiratory Medicine Source Type: news

HPV Causes Cancer — A Vaccine Can Prevent It
More than 30,000 Americans develop one of several kinds of cancer each year caused by the human papillomavirus (HPV) — some of which will kill them. Fortunately, physicians say a too-seldom-used vaccine can protect people from HPV-caused cancers of the cervix, vulva, vagina, penis, anus, and oropharynx (head and neck). (Source: TMA News Room)
Source: TMA News Room - March 1, 2018 Category: Consumer Health News Source Type: news

HPV in Tonsil Biofilm May Play Role in Oropharyngeal Cancer HPV in Tonsil Biofilm May Play Role in Oropharyngeal Cancer
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Dentists may soon start asking about your sex life
New research from the ‎University of South Florida College of Public Health say dentists should help reduce the rate of oral cancers by checking for symptoms of HPV-related oropharyngeal cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - January 16, 2018 Category: Consumer Health News Source Type: news

More dentists to discuss risks of HPV-related cancers with their patients
(University of South Florida (USF Health)) The dental community is working to strengthen HPV prevention efforts, helping reduce the prevalence of oropharyngeal cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2018 Category: Cancer & Oncology Source Type: news

An Interprofessional Approach to HPV and Oropharyngeal Cancer Prevention Education
February 21, 2018 2:00-3:00pm ET. (Source: PHPartners.org)
Source: PHPartners.org - January 8, 2018 Category: International Medicine & Public Health Source Type: news

GERD Linked to Upper Aerodigestive Tract Cancers
In elderly, tied to higher odds of malignancy in larynx, hypopharynx, oropharynx, nasopharynx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 26, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, ENT, Pathology, Journal, Source Type: news

$6.6 million grant will fund UCLA-led study on how to increase use of HPV vaccine
The discovery of human papillomavirus, or HPV, as a major cause of many cancers — including cervical, anal, oropharyngeal, vaginal, vulvar and penile — and the subsequent development of prophylactic HPV vaccines was a revolution in cancer prevention.But 10 years after the vaccine ’s introduction, HPV vaccination rates among U.S. adolescents remain unacceptably low. Now, a five-year study led by UCLA cancer researcher Roshan Bastani will examine the comparative effectiveness of strategies designed to increase the number of adolescents who receive the HPV vaccine. The work i s being funded by a $6.6 million...
Source: UCLA Newsroom: Health Sciences - December 8, 2017 Category: Universities & Medical Training Source Type: news

FDA recognizes radiotherapy readiness standard
The U.S. Food and Drug Administration (FDA) has recognized the RT-2 Radiotherapy...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer Radiotherapy boost based on PET not always helpful ASTRO releases oropharyngeal cancer guidelines ASTRO updates guidelines on painful bone metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2017 Category: Radiology Source Type: news

Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS? Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS?
For patients with oropharyngeal squamous cell carcinoma (OPSCC) receiving transoral robotic surgery (TORS), adjuvant radiotherapy or chemoradiotherapy (CRT) should be avoided if possible, according to a long-term functional and quality-of-life (QOL) outcomes study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 6, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Risk for HPV-Related Throat Cancer Is'Reassuringly' Low Risk for HPV-Related Throat Cancer Is'Reassuringly' Low
Despite recent reports about the incidence of HPV infection in this area of the body, HPV-associated oropharyngeal cancer remains uncommon, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Better Outcomes With Transoroal Robotic Surgery Alone in OPSCC
Significantly quicker improvement in postoperative dysphagia in oropharyngeal cancer TORS - only group (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 27, 2017 Category: Cancer & Oncology Tags: Oncology, ENT, Radiology, Surgery, Journal, Source Type: news

Men who perform oral sex on women 'more at risk of mouth and throat cancers'
Conclusion This study uses a large amount of national data to give us an idea about which groups of people have the greatest risk of carrying potentially cancer-causing oral HPV . But while oral HPV may increase people's risk of mouth and throat cancers, the actual number who would go on to develop cancer is extremely small. This study has limitations, which are worth bearing in mind: It only looked at whether people had oral HPV at a single point in time. This makes it difficult to know at what point they became infected and how much this could be down to other risk factors such as smoking, oral sex and number of partne...
Source: NHS News Feed - October 20, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Reduced-Dose RT Controls HPV+ Oropharynx Cancer (CME/CE)
(MedPage Today) -- Dramatic decline in toxicity (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 26, 2017 Category: Consumer Health News Source Type: news

David Sher on the Updated ASTRO Guidelines for Oropharyngeal Cancer
In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer. (Source: CancerNetwork)
Source: CancerNetwork - September 15, 2017 Category: Cancer & Oncology Authors: David J. Sher, MD, MPH Tags: Head & Neck Cancer Oncology Journal Q Source Type: news

Hefty Price for HPV+ Oropharyngeal Cancer (CME/CE)
(MedPage Today) -- Healthcare costs approaching $140,000 for 2 years of care (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 25, 2017 Category: American Health Source Type: news

Average cost of first 2 years of oropharyngeal cancer treatment in Texas is $139,749
(American Association for Cancer Research) In Texas, the average cost for the first two years of health care after a diagnosis of oropharyngeal cancer was $139,749. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news

Newly developed nomograms provide accurate predictions for patients with oropharyngeal cancer
(NRG Oncology) NRG Oncology researchers recently developed and validated a nomogram that can predict 2-year and 5-year overall survival (OS) and progression-free survival (PFS) for patients with local-regionally advanced oropharyngeal squamous cell carcinoma (OPSCC) treated primarily with radiation-based therapy. This nomogram was developed with data from clinical trials NRG Oncology/RTOG 0129 and 0522. Results were published online in the Journal of Clinical Oncology on Aug. 4, 2017. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 21, 2017 Category: Cancer & Oncology Source Type: news

Oropharyngeal Cancer Treatment
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 1, 2017 Category: General Medicine Source Type: news

ASTRO bestows grants to survivor groups
The American Society for Radiation Oncology (ASTRO) has named two recipients...Read more on AuntMinnie.comRelated Reading: ASTRO names Gold Medal winners ASTRO publishes new guideline for SBRT in lung cancer ASTRO releases oropharyngeal cancer guidelines ASTRO partners with ASCO's CancerLinQ ASTRO updates guidelines on painful bone metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2017 Category: Radiology Source Type: news

HPV Vaccination Prevents Cancers in Men, Too
For years, scientists have touted the HPV vaccination ’s power to reduce cervical cancer in women. Now, during Men’s Health Week, Texas physicians urge men to get vaccinated against HPV to prevent cancers. HPV causes several cancers in men and women, including oropharyngeal (cancers of the head and neck such as the throat and mouth), penile, anal, cervical and vaginal. Some cases are fatal. (Source: TMA News Room)
Source: TMA News Room - June 14, 2017 Category: Consumer Health News Source Type: news

ASTRO publishes new guideline for SBRT in lung cancer
The American Society for Radiation Oncology (ASTRO) has released a new clinical...Read more on AuntMinnie.comRelated Reading: Societies release guideline for localized prostate cancer ASTRO releases oropharyngeal cancer guidelines ASTRO partners with ASCO's CancerLinQ ASTRO updates guidelines on painful bone metastases Elekta to support ASTRO safety initiative (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 13, 2017 Category: Radiology Source Type: news